148 related articles for article (PubMed ID: 6815841)
1. Effect of delayed refrigeration on plasma factors in whole blood collected in CPDA-2.
Sohmer PR; Bolin RB; Scott RL; Smith DJ
Transfusion; 1982; 22(6):488-90. PubMed ID: 6815841
[TBL] [Abstract][Full Text] [Related]
2. The biochemical effects of CPDA-2-drawn red blood cells of delayed refrigeration prior to component preparation.
Moore GL; Ledford ME; Merydith A
Transfusion; 1982; 22(6):485-7. PubMed ID: 7147327
[TBL] [Abstract][Full Text] [Related]
3. In vivo viability of red blood cells stored in CPDA-2.
Sohmer PR; Moore GL; Beutler E; Peck CC
Transfusion; 1982; 22(6):479-84. PubMed ID: 7147326
[TBL] [Abstract][Full Text] [Related]
4. Survival and biochemical characteristics of stored red cells preserved with citrate-phosphate-dextrose-adenine-one and two and prepared from whole blood maintained at 20 to 24 degrees C for eight hours following phlebotomy.
Moroff G; Morse EE; Katz AJ; Kahn RA; Dende D; Swatman L; Staggs SD
Transfusion; 1984; 24(2):115-9. PubMed ID: 6710583
[TBL] [Abstract][Full Text] [Related]
5. An in vivo comparison of CPD and CPDA-2 preserved platelet concentrates after an 8-hour preprocess hold of whole blood.
Bolin RB; Cheney BA; Smith DJ; Gildengorin V; Shigekawa R
Transfusion; 1982; 22(6):491-5. PubMed ID: 7147328
[TBL] [Abstract][Full Text] [Related]
6. Modified formulation of CPDA for storage of whole blood, and of SAGM for storage of red blood cells, to maintain the concentration of 2,3-diphosphoglycerate.
Kurup PA; Arun P; Gayathri NS; Dhanya CR; Indu AR
Vox Sang; 2003 Nov; 85(4):253-61. PubMed ID: 14633250
[TBL] [Abstract][Full Text] [Related]
7. Cold-stored leukoreduced CPDA-1 whole blood: in vitro quality and hemostatic properties.
Sivertsen J; Braathen H; Lunde THF; Kristoffersen EK; Hervig T; Strandenes G; Apelseth TO
Transfusion; 2020 May; 60(5):1042-1049. PubMed ID: 32187700
[TBL] [Abstract][Full Text] [Related]
8. Characterization of biochemical changes occurring during storage of red cells. Comparative studies with CPD and CPDA-1 anticoagulant-preservative solutions.
Moroff G; Dende D
Transfusion; 1983; 23(6):484-9. PubMed ID: 6649025
[TBL] [Abstract][Full Text] [Related]
9. Impact of the anticoagulant-preservative citrate-phosphate-adenine (CPDA-1) on blood services.
McEvoy PM; Kahn RA; Miller WV
Transfusion; 1982; 22(6):532-4. PubMed ID: 7147334
[TBL] [Abstract][Full Text] [Related]
10. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
[TBL] [Abstract][Full Text] [Related]
11. Circulation and function of human platelets isolated from units of CPDA-1, CPDA-2, and CPDA-3 anticoagulated blood and frozen with DMSO.
Vecchione JJ; Melaragno AJ; Hollander A; Defina S; Emerson CP; Valeri CR
Transfusion; 1982; 22(3):206-9. PubMed ID: 7090033
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell aging markers during storage in citrate-phosphate-dextrose-saline-adenine-glucose-mannitol.
Antonelou MH; Kriebardis AG; Stamoulis KE; Economou-Petersen E; Margaritis LH; Papassideri IS
Transfusion; 2010 Feb; 50(2):376-89. PubMed ID: 19874562
[TBL] [Abstract][Full Text] [Related]
13. Manufacture of red cells in additive solution from whole blood refrigerated for 5 days or remanufactured from red cells stored in plasma.
Wiltshire M; Cardigan R; Thomas S
Transfus Med; 2010 Dec; 20(6):383-91. PubMed ID: 20681977
[TBL] [Abstract][Full Text] [Related]
14. The effect of pre-storage whole-blood leukocyte reduction on cytokines/chemokines levels in autologous CPDA-1 whole blood.
Nagura Y; Tsuno NH; Tanaka M; Matsuhashi M; Takahashi K
Transfus Apher Sci; 2013 Oct; 49(2):223-30. PubMed ID: 23462351
[TBL] [Abstract][Full Text] [Related]
15. Adequate survival of red cells from units "undercollected" in citrate-phosphate-dextrose-adenine-one.
Davey RJ; Lenes BL; Casper AJ; Demets DL
Transfusion; 1984; 24(4):319-22. PubMed ID: 6464155
[TBL] [Abstract][Full Text] [Related]
16. Lipid peroxidation compared in stored whole blood with various nutrient-anticoagulant solutions.
Knight JA; Searles DA; Blaylock RC
Ann Clin Lab Sci; 1993; 23(3):178-83. PubMed ID: 8323251
[TBL] [Abstract][Full Text] [Related]
17. Dihydroxyacetone, pyruvate, and phosphate effects on 2,3 DPG and ATP in citrate-phosphate-dextrose-adenine blood preservation.
Dawson RB; Fagan DS; Meyer DR
Transfusion; 1984; 24(4):327-9. PubMed ID: 6464157
[TBL] [Abstract][Full Text] [Related]
18. The preparation of fibrinogen concentrate for use as fibrin glue by four different methods.
DePalma L; Criss VR; Luban NL
Transfusion; 1993 Sep; 33(9):717-20. PubMed ID: 8212116
[TBL] [Abstract][Full Text] [Related]
19. The bioequivalence of frozen plasma prepared from whole blood held overnight at room temperature compared to fresh-frozen plasma prepared within eight hours of collection.
Dumont LJ; Cancelas JA; Maes LA; Rugg N; Whitley P; Herschel L; Siegel AH; Szczepiorkowski ZM; Hess JR; Zia M
Transfusion; 2015 Mar; 55(3):476-84. PubMed ID: 25233805
[TBL] [Abstract][Full Text] [Related]
20. Effect of 24-hour whole-blood storage on plasma clotting factors.
O'Neill EM; Rowley J; Hansson-Wicher M; McCarter S; Ragno G; Valeri CR
Transfusion; 1999 May; 39(5):488-91. PubMed ID: 10335998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
